Patents by Inventor Bharatkumar H. Joshi

Bharatkumar H. Joshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11352402
    Abstract: The present invention relates to interleukin-4 receptor-binding fusion proteins. More specifically, the invention provides, in part, fusion proteins that include an interleukin-4 or interleukin-13 protein moiety joined to an anti-apoptotic Bcl-2 family member protein moiety.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: June 7, 2022
    Assignee: MEDICENNA THERAPEUTICS, INC.
    Inventors: Fahar Merchant, Raj K. Puri, Bharatkumar H. Joshi
  • Publication number: 20220048965
    Abstract: The present invention relates to interleukin-4 receptor binding fusion proteins. More specifically, the invention provides, in part, fusion proteins that include an interleukin-4 receptor binding protein moiety joined to a pro-apoptotic Bcl-2 family member protein moiety.
    Type: Application
    Filed: August 9, 2021
    Publication date: February 17, 2022
    Inventors: Fahar Merchant, Raj K. Puri, Bharatkumar H. Joshi
  • Patent number: 11084856
    Abstract: The present invention relates to interleukin-4 receptor binding fusion proteins. More specifically, the invention provides, in part, fusion proteins that include an interleukin-4 receptor binding protein moiety joined to a pro-apoptotic Bcl-2 family member protein moiety.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: August 10, 2021
    Assignees: Medicenna Therapeutics, Inc., The United States of America, as represented by the Secretary, Departnemt of Health and Human Services
    Inventors: Fahar Merchant, Raj K. Puri, Bharatkumar H. Joshi